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rightly draws attention to difficulties encountered in telemedicine trials. We do agree that results obtained via telemedicine need to be compared with those obtained via traditional practice. As he says, most of the work to date has concerned teleradiology and little is known about the diagnostic accuracy of other telemedicine applications. We have assessed the Spirophone, which allows expiratory pulmonary function tests at home and transmission via telephone to a remote-receiving centre. The Spirophone records maximal forced expiratory manoeuvres with acceptable accuracy, reliability, and reproducibility1-3.
We found it comparable to a standard laboratory spirometer for home monitoring of SVC, FVC, FEV1, and PEF4. The validity of the manoeuvre can be assessed on screen in the remote receiving centre in real time, and when necessary expert advice can be transmitted. We think that such a system could improve the management of asthma, cystic fibrosis and other respiratory diseases.
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